Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma
暂无分享,去创建一个
Sheung Tat Fan | Chang Xian Li | S. Fan | K. Man | C. Lo | K. Ng | X. Qi | C. Ling | W. Geng | Kwan Man | Chung Mau Lo | Q. Lian | X. Liu | Yuen-yuen Ma | W. Yeung | W. Tu | Xiang Qi | Kevin Tak Pan Ng | Qi Zhou Lian | Xiao Bing Liu | Wei Geng | Chang Chun Ling | Yuen Yuen Ma | Wai Ho Yeung | Wen Wei Tu | C. Li | K. Ng
[1] S. Fan,et al. Hepatectomy for hepatocellular carcinoma: Patient selection and postoperative outcome , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[2] Liangen Shi,et al. Saponins from Panax japonicus protect against alcohol-induced hepatic injury in mice by up-regulating the expression of GPX3, SOD1 and SOD3. , 2010, Alcohol and alcoholism.
[3] C. Siu,et al. Functional Mesenchymal Stem Cells Derived From Human Induced Pluripotent Stem Cells Attenuate Limb Ischemia in Mice , 2010, Circulation.
[4] S. Ye,et al. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. , 2001, World journal of gastroenterology.
[5] P. Brecher,et al. Temporal control of NF-kappaB activation by ERK differentially regulates interleukin-1beta-induced gene expression. , 2004, The Journal of biological chemistry.
[6] Harish Srinivasan,et al. Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[7] C. Moskaluk,et al. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. , 2005, Neoplasia.
[8] M. Sherman,et al. Screening for hepatocellular carcinoma , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.
[9] C. Boland,et al. Oxidative stress increases frameshift mutations in human colorectal cancer cells. , 2001, Cancer research.
[10] P. Brecher,et al. Temporal Control of NF-κB Activation by ERK Differentially Regulates Interleukin-1β-induced Gene Expression* , 2004, Journal of Biological Chemistry.
[11] S. Fan,et al. The Role of Proline Rich Tyrosine Kinase 2 (Pyk2) on Cisplatin Resistance in Hepatocellular Carcinoma , 2011, PloS one.
[12] Jian-Hua Luo,et al. p53-induced Gene 3 Mediates Cell Death Induced by Glutathione Peroxidase 3* , 2012, The Journal of Biological Chemistry.
[13] I. Ng,et al. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma , 2007, The British journal of surgery.
[14] Aristotelis Tsirigos,et al. The autophagic tumor stroma model of cancer , 2010, Cell cycle.
[15] J. Yodoi,et al. Aberrant expression of selenoproteins in the progression of colorectal cancer. , 2008, Cancer letters.
[16] George Tseng,et al. Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. , 2007, Cancer research.
[17] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[18] L. Nelles,et al. Activation of NF-κB by Akt upregulates Snail expression and induces epithelium mesenchyme transition , 2007, Oncogene.
[19] Kimberly Walter,et al. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. , 2010, Cancer research.
[20] S. Fan,et al. Molecular Signature Linked to Acute Phase Injury and Tumor Invasiveness in Small-for-Size Liver Grafts , 2010, Annals of surgery.
[21] K. Washington,et al. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett’s adenocarcinoma , 2008, Gut.
[22] S. Fan,et al. Liver transplantation for hepatocellular carcinoma: the Hong Kong experience , 2010, Journal of hepato-biliary-pancreatic sciences.
[23] A. Jemal,et al. Global Cancer Statistics , 2011 .
[24] G. Hardy,et al. Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill? , 2009, Intensive Care Medicine.
[25] Xian-Yang Zhang,et al. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases , 2005, Expert opinion on biological therapy.
[26] R. Gaynor,et al. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.
[27] M. Matúšková,et al. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. , 2007, Cancer research.
[28] M. Andreeff,et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.
[29] Shengtao Zhu,et al. Identification of GPX3 Epigenetically Silenced by CpG Methylation in Human Esophageal Squamous Cell Carcinoma , 2011, Digestive Diseases and Sciences.
[30] A. Befeler,et al. Hepatocellular carcinoma: diagnosis and treatment. , 2002, Gastroenterology.
[31] Su Jin Lee,et al. Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma , 2012, Investigational New Drugs.
[32] Songhee Jeon,et al. Impaired PI3K/Akt Activation-Mediated NF-κB Inactivation Under Elevated TNF-α Is More Vulnerable to Apoptosis in Vitiliginous Keratinocytes , 2007 .
[33] E. Wu,et al. Suppression of Liver Tumor Growth and Metastasis by Adiponectin in Nude Mice through Inhibition of Tumor Angiogenesis and Downregulation of Rho Kinase/IFN-Inducible Protein 10/Matrix Metalloproteinase 9 Signaling , 2010, Clinical Cancer Research.
[34] S. Badve,et al. NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2 , 2007, Oncogene.
[35] W. Ahn,et al. An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer. , 2009, International journal of oncology.
[36] Joon-Oh Park,et al. Prognostic Factors in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Retrospective Comparison with Previously Known Prognostic Models , 2011, Oncology.
[37] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[38] W. Youden,et al. Index for rating diagnostic tests , 1950, Cancer.
[39] P. Chiarugi,et al. Oxidative Stress, Tumor Microenvironment, and Metabolic Reprogramming: A Diabolic Liaison , 2012, International journal of cell biology.
[40] Daryl A. Scott,et al. Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development , 2007, Development.
[41] Songhee Jeon,et al. Impaired PI3K/Akt activation-mediated NF-kappaB inactivation under elevated TNF-alpha is more vulnerable to apoptosis in vitiliginous keratinocytes. , 2007, The Journal of investigative dermatology.
[42] Daryl A. Scott,et al. Dusp 6 ( Mkp 3 ) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development , 2022 .
[43] S. Zucker,et al. Angiogenesis , Metastasis , and the Cellular Microenvironment Oxidative Stress and Prostate Cancer Progression Are Elicited by Membrane-Type 1 Matrix Metalloproteinase , 2011 .
[44] Caitlyn W. Barrett,et al. Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma. , 2013, Cancer research.
[45] C. Kay,et al. Hepatocellular carcinoma with portal vein tumor thrombosis: Improved treatment outcomes with external beam radiation therapy , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.